Target intelligence / Profile preview

Wound environment components

Molecular classification
Other
01

Overview

The wound environment components represent a complex, multi-faceted milieu consisting of cells, signaling molecules, and the extracellular matrix (ECM) that collectively coordinate tissue repair (StatPearls, Wound Healing, 2023). Key cellular participants include fibroblasts, keratinocytes, and various immune cells like macrophages, which transition from pro-inflammatory to pro-remodeling phenotypes to facilitate closure (NIH, PMC4150575). The acellular component is dominated by ECM proteins such as collagen and fibronectin, which provide structural support and biochemical cues for cell migration and proliferation (PubMed, 26139479). In pathological states like diabetic foot ulcers or pressure sores, the environment becomes stalled in a chronic inflammatory phase characterized by high levels of matrix metalloproteinases (MMPs) that degrade essential growth factors (Journal of Investigative Dermatology, 2007). Therapeutic strategies targeting this environment include the application of exogenous growth factors like Becaplermin or enzymatic debriders like collagenase to remove inhibitory necrotic tissue (FDA, Regranex Label). Because this term refers to a broad physiological system rather than a single molecular entity, it is generally considered a therapeutic setting or microenvironment rather than a specific drug target.

Other names
Wound microenvironmentWound milieuWound exudateExtracellular matrix of wounds
02

Mechanism of action

Modulation of the inflammatory phase, enzymatic debridement of necrotic tissue, and provision of growth factors or scaffolds to promote cellular proliferation and extracellular matrix synthesis.

03

Biological functions

Tissue repairInflammationAngiogenesisCell migrationExtracellular matrix remodeling
04

Disease associations

Chronic woundsDiabetic foot ulcersPressure ulcersFibrosisInfection
05

Safety considerations

Hypersensitivity reactionsSystemic toxicity from topical absorptionRisk of secondary infectionImpaired healing due to excessive moisture or dryness
06

Interacting drugs

Becaplermin

4 more in the full profile.

07

Biomarkers

Matrix metalloproteinase-9 (MMP-9)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)LactateExudate pH

Beyond the preview

Go deeper on Wound environment components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wound environment components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call